Meta-analysis of CMR biomarkers in diabetes shows elevated ECV and reduced perfusion
This is a systematic review and meta-analysis of cardiac magnetic resonance (CMR) biomarkers in patients with diabetes mellitus. The scope was to synthesize evidence on extracellular volume fraction (ECV), myocardial perfusion reserve index (MPRI), and late gadolinium enhancement (LGE).
The authors found that ECV was significantly elevated, with a pooled standardized mean difference (SMD) of 0.838 (p = 0.003). MPRI was reduced, with an SMD of 1.48 (p = 0.033). LGE showed a higher prevalence, with an SMD of 0.583; the p-value was not reported.
The analysis included over 3,900 patients. The authors did not report specific study settings, follow-up durations, or primary outcomes. Safety data and funding conflicts were not reported.
Limitations noted by the authors include the observational nature of the included studies, which precludes causal inference. The review does not report absolute event rates or clinical outcomes.
Clinicians can consider these biomarker alterations as potential indicators of myocardial involvement in diabetes, but the findings require validation in prospective studies.